🔎 Trials Near Me

Akèy › Kansè kolorektal › Florid › Sarasota

Etid klinik pou Kansè kolorektal nan Sarasota, FL

16 etid pou Kansè kolorektal ap chèche patisipan nan sit nan ak bò kote Sarasota (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

Ap rekriteFaz 1
  • Florida Cancer Specialists and Research Institute, Sarasota
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT07454642

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

Ap rekriteFaz 1
  • Florida Cancer Specialists & Research Institute - Sarasota Cattlemen, Sarasota
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07578571

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Ap rekriteFaz 3
  • Florida Cancer Specialists, Sarasota
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07222800

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

Ap rekriteFaz 1
  • Florida Cancer Specialists, Sarasota
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06663319

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Ap rekriteFaz 1/2
  • Florida Cancer Specialists, Sarasota
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Ap rekriteFaz 1/2
  • Florida Cancer Specialists & Research Institute - Sarasota, Sarasota
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07629960

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • Florida Cancer Specialist, Sarasota
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06440005

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1
  • Florida Cancer Specalists, Sarasota
Laj 18 a 99 · Tout sèks · Mizajou Sep 1, 2026 · NCT06983743

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Ap rekriteFaz 1
  • SCRI FCS Sarasota, Sarasota
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT07227168

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

Ap rekriteFaz 1
  • Sarah Cannon Research Institute, Sarasota
Laj 18 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT07066657

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Florida Cancer Specialists, Sarasota
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT04657068

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

Ap rekriteFaz 1
  • Florida Cancer Specialists, Sarasota
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT06179160

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Ap rekriteFaz 1
  • Florida Cancer Specialists, Sarasota
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT07458347

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Ap rekriteFaz 1
  • Florida Cancer Specialists, Sarasota
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2026 · NCT07503808

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Ap rekriteFaz 1
  • Florida Cancer Specialists, Sarasota
Laj 18 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT06026410

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Ap rekriteFaz 1
  • Florida Cancer Specialists, Sarasota
Laj 18 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT06040541

Etid Kansè kolorektal nan lòt vil

Lòt etid nan Sarasota

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.